New cytotoxic drugs for intrathecal administration

被引：24

作者：

Blaney, SM ^{[1
]}

Poplack, DG ^{[1
]}

机构：

[1] Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat, Houston, TX 77030 USA

来源：

JOURNAL OF NEURO-ONCOLOGY | 1998年 / 38卷 / 2-3期

关键词：

intrathecal; leptomeningeal; mafosfamide; topotecan; diaziquone;

D O I：

10.1023/A:1005944622003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：219 / 223

页数：5

共 11 条

[1] DIAZIQUONE, 2,5-DIAZIRIDINYL-3,6-BISCARBOETHOXYAMINO-1,4-BENZOQUINONE, PLASMA AND CEREBROSPINAL-FLUID KINETICS [J].

BACHUR, NR ;

COLLINS, JM ;

KELLEY, JA ;

VANECHO, DA ;

KAPLAN, RS ;

WHITACRE, M .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (05) :650-655

[2] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF THE NEW ANTITUMOR DRUG SK-AND-F 104864-A (NSC 609699) IN PLASMA [J].

BEIJNEN, JH ;

SMITH, BR ;

KEIJER, WJ ;

VANGIJN, R ;

HUININK, WWT ;

VLASVELD, LT ;

RODENHUIS, S ;

UNDERBERG, WJM .

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1990, 8 (8-12) :789-794

[3] PHASE-I PHASE-II TRIAL AND PHARMACOKINETICS OF INTRATHECAL DIAZIQUONE IN REFRACTORY MENINGEAL MALIGNANCIES [J].

BERG, SL ;

BALIS, FM ;

ZIMM, S ;

MURPHY, RF ;

HOLCENBERG, J ;

SATO, J ;

REAMAN, G ;

STEINHERZ, P ;

GILLESPIE, A ;

DOHERTY, K ;

POPLACK, DG .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) :143-148

[4]

BLANEY S, 1992, P AN M AM SOC CLIN, V11, P113

[5]

BLANEY SM, 1993, CANCER RES, V53, P725

[6]

Blaney SM, 1995, CANCER CHEMOTH PHARM, V36, P121

[7]

CURT GA, 1983, CANCER RES, V43, P6102

[8]

EGORIN MJ, 1985, CANCER RES, V45, P992

[9] MODIFICATION OF THE HYDROXY LACTONE RING OF CAMPTOTHECIN - INHIBITION OF MAMMALIAN TOPOISOMERASE-I AND BIOLOGICAL-ACTIVITY [J].

HERTZBERG, RP ;

CARANFA, MJ ;

HOLDEN, KG ;

JAKAS, DR ;

GALLAGHER, G ;

MATTERN, MR ;

MONG, SM ;

BARTUS, JO ;

JOHNSON, RK ;

KINGSBURY, WD .

JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (03) :715-720

[10]

MCCULLY CL, 1990, LAB ANIM SCI, V40, P520

← 1 2 →